$IMPL 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Impel NeuroPharma, Inc. is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for people suffering from diseases with high unmet needs, with an initial focus on diseases of the CNS. The Company’s strategy is to rapidly advance its product candidate pipeline that pairs its proprietary Precision Olfactory Delivery (POD®) system with well-established therapeutics, including TRUDHESA™ for the acute treatment of migraine, INP105 for the acute treatment of agitation and aggression in patients with autism, and INP107 for OFF episodes in Parkinson’s disease.

CEO

Michael Hite

Exchange

NASDAQ

Website

impelnp.com

$M

Total Revenue

59

Employees

$182M

Market Capitalization

-3.76

Price/Earning ratio

Similar Companies

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Charles River Laboratories Int CRL 21115 3273 9.00 53.28 12.10
Exact Sciences Corp. EXAS 15524 1712 4.63 -17.52 -49.89
PRA Health Sciences Inc PRAH 10739 3333 6.88 50.52 6.40
Syneos Health Inc SYNH 9147 4730 2.78 38.89 4.99
Medpace Holdings Inc MEDP 7055 1028 7.81 40.02 17.02
Exelixis Inc EXEL 6902 1157 3.31 74.14 8.13
Twist Bioscience Corp TWST 5634 127 9.68 -42.81 -106.59
Allakos Inc ALLK 5438 9.89 -27.30 None
Vir Biotechnology Inc VIR 5162 183 7.14 -17.02 -162.74
Sana Biotechnology Inc SANA 3669 4.21 -11.20 None
Recursion Pharmaceuticals Inc RXRX 3242 9 5.07 -26.44 None
Lyell Immunopharma Inc LYEL 3126 8 3.06 -16.15 None
Instil Bio Inc TIL 2312 0 3.63 -28.00 None
Alx Oncology Holdings Inc ALXO 2166 1 5.39 -18.67 -401.23
Verve Therapeutics Inc VERV 2083 5.13 -21.06 None
Allogene Therapeutics Inc ALLO 2062 38 2.19 -8.60 -621.84
Erasca Inc ERAS 2055 -14.41 -16.25 None
Sorrento Therapeutics Inc SRNE 1840 51 11.05 -5.81 -626.43
Cortexyme Inc CRTX 1710 11.90 -19.39 None
Constellation Pharmaceuticals CNST 1564 4.32 -11.18 None
Castle Biosciences Inc CSTL 1554 78 4.09 -66.91 -28.88
Pandion Therapeutics Inc PAND 1501 1069 1.83 -13.34 -10.55
AlloVir Inc ALVR 1480 0 5.06 -12.56 -718.59
Replimune Group Inc REPL 1458 2.91 -16.17 None
Organogenesis Holdings Inc ORGO 1372 433 7.83 18.15 16.17
Rubius Therapeutics Inc RUBY 1330 5.45 -7.67 None
Y-Mabs Therapeutics Inc YMAB 1138 37 4.92 -24.73 -114.04
National Research Corp NRC 1129 140 14.47 31.01 25.62
Caribou Biosciences Inc CRBU 1098 5 -24.96 -21.71 -955.31
Century Therapeutics Inc IPSC 1076 2.42 -15.44 None
Monte Rosa Therapeutics Inc GLUE 1016 2.94 -17.64 None
Cullinan Oncology Inc CGEM 946 19 2.06 -17.35 -284.59
Scholar Rock Holding Corp SRRK 901 16 4.21 -8.33 -687.82
Precigen Inc PGEN 898 101 6.34 -8.13 -107.45
Janux Therapeutics Inc JANX 882 1 2.33 -76.82 -436.67
RAPT Therapeutics Inc RAPT 803 5 4.35 -13.37 7.14
Sutro Biopharma Inc STRO 792 69 2.83 -8.69 -114.69
Imago BioSciences Inc IMGO 776 -9.97 -29.79 None
Design Therapeutics Inc DSGN 765 0 1.91 -39.74 -245.44
MeiraGTx Holdings plc MGTX 723 19 3.80 -12.51 -325.95
Graphite Bio Inc GRPH 718 1.96 -14.58 None
Ideaya Biosciences Inc IDYA 709 36 3.65 -27.21 -84.49
Crinetics Pharmaceuticals Inc CRNX 693 0 3.99 -7.81 -447.78
Talaris Therapeutics Inc TALS 646 2.43 -18.98 None
Precision Biosciences Inc DTIL 556 101 5.88 -11.16 -45.88
Vor Biopharma Inc VOR 546 2.19 -8.34 None
Acumen Pharmaceuticals Inc ABOS 541 1 -5.30 -5.57 -550.91
Rallybio Corp RLYB 526 38 -7.86 -12.39 -1.07
Mirum Pharmaceuticals Inc MIRM 463 11 5.26 -3.04 None
Werewolf Therapeutics Inc HOWL 457 2.47 -2.45 None
Kezar Life Sciences Inc KZR 449 3.26 -9.36 None
Applied Therapeutics Inc APLT 430 14 3.84 -3.77 -19.41
Evelo Biosciences Inc EVLO 408 7.18 -3.86 None
Cue Biopharma Inc CUE 367 5 5.30 -8.50 -802.84
Oyster Point Pharma Inc OYST 360 2.38 -4.51 None
Vera Therapeutics Inc VERA 355 3.91 -6.48 None
Biomea Fusion Inc BMEA 340 1.68 -18.06 None
Sera Prognostics Inc SERA 335 0 -2.33 -14.21 None
Surface Oncology Inc SURF 329 90 2.35 14.71 18.99
Aerovate Therapeutics Inc AVTE 328 -16.22 -22.30 None
Magenta Therapeutics Inc MGTA 325 1.88 -4.68 None
Cabaletta Bio Inc CABA 312 3.20 -8.02 None
Luna Innovations Inc LUNA 299 101 3.70 129.57 2.46
Black Diamond Therapeutics Inc BDTX 284 1.14 -2.71 None
INmune Bio Inc INMB 256 0 7.54 -13.13 None
Pieris Pharmaceuticals Inc PIRS 253 24 6.35 -5.23 -203.73
Compass Therapeutics Inc CMPX 253 8.68 -3.11 None
Candel Therapeutics Inc CADL 247 0 -6.58 -7.10 None
Nextcure Inc NXTC 241 22 0.90 -3.56 -163.57
Sensei Biotherapeutics Inc SNSE 218 1.32 -7.63 None
AquaBounty Technologies Inc AQB 216 0 1.23 -10.59 None
Gemini Therapeutics Inc GMTX 211 1088 0.23 1.74 11.24
Alzamend Neuro Inc ALZN 197 12.61 -32.43 None
Impel NeuroPharma Inc. IMPL 182 3.65 -3.76 None
Elevation Oncology Inc ELEV 179 1.16 -8.02 None
Tscan Therapeutics Inc TCRX 174 6 -2.90 -5.07 -563.14
Hookipa Pharma Inc HOOK 152 20 1.20 -2.48 -304.07
Reneo Pharmaceuticals Inc RPHM 151 0.92 -5.54 None
Unity Biotechnology Inc UBX 124 1 1.93 -1.53 None
IN8bio Inc INAB 112 -5.24 -11.17 None
HCW Biologics Inc HCWB 109 4 -4.95 -16.95 -162.03
Exicure Inc XCUR 104 4 2.81 -2.19 -148.49
Axcella Health Inc AXLA 103 2700 2.21 -1.84 -10.84
Cyclerion Therapeutics Inc CYCN 90 4 1.76 -1.34 None
BioVie Inc BIVI 72 29.90 -0.40 None
Scopus Biopharma Inc SCPS 70 234 -35.55 -3.34 80.93
Eloxx Pharmaceuticals Inc ELOX 70 0 3.17 -1.28 -14.14
Synaptogenix Inc SNPX 65 2.05 -4.31 None
Monopar Therapeutics Inc MNPR 60 2.68 -7.56 None
NanoViricides Inc NNVC 54 1.88 -6.05 None
CohBar Inc CWBR 53 4.84 -3.17 None
Rezolute Inc RZLT 53 3.91 -2.43 None
Acurx Pharmaceuticals Inc ACXP 48 3.14 -6.00 None
Vaccinex Inc VCNX 47 1 3.53 -1.66 -48.71
Cyclo Therapeutics Inc CYTH 39 1 3.77 -1.86 -989.80
TransCode Therapeutics Inc RNAZ 38 -8.08 -10.86 None
Unicycive Therapeutics Inc UNCY 36 113 -8.79 -9.81 7.94
AgeX Therapeutics Inc AGE 35 2 -4.18 -3.68 -522.77
Aridis Pharmaceuticals Inc ARDS 35 0 -3.79 -1.40 -851.00
Cytocom Inc CBLI 30 0 3.88 -12.72 -912.16
Tenax Therapeutics Inc TENX 18 0 27.83 -0.71 -840.64
Geovax Labs Inc GOVX 16 1 1.30 -11.11 -558.09
Kiromic BioPharma Inc KRBP 15 6.91 -1.10 None
Xenetic Biosciences Inc XBIO 14 1 1.73 -1.07 -47.40
Neurotrope Inc NTRP 5 29 0.08 0.76 23.48

One Impel NeuroPharma, Inc. (NASDAQ:IMPL) insider upped their stake in the previous year

1d ago, source: YAHOO!Finance

From what we can see, insiders were net buyers in Impel NeuroPharma, Inc.'s ( NASDAQ:IMPL ) during the past 12 ...

Impel NeuroPharma Inc. (IMPL) distance from 20-day Simple moving Average is -17.14%: What to Expect?

7d ago, source: investchronicle

At the end of the latest market close, Impel NeuroPharma Inc. (IMPL) was valued at $9.42. In that particular session, Stock kicked-off at the price of $9.41 while reaching the peak value of $10.7499 ...

Impel NeuroPharma Announces U.S. FDA Approval of TRUDHESA(TM) (Dihydroergotamine Mesylate) Nasal Spray for the Acute Treatment of Migraine

1mon ago, source: Stockhouse

SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases ...

Impel NeuroPharma Announces Trudhesa™ (Dihydroergotamine Mesylate) Nasal Spray is Now Available ...

22d ago, source: Omaha.com

28, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high ...

Impel NeuroPharma Inc IMPL

5d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...

Impel NeuroPharma Says Trudhesa Available for Prescription, Shares up

21d ago, source: MarketWatch

Impel NeuroPharma Inc. shares rose Tuesday after the biopharmaceutical company said its Trudhesa nasal spray for the treatment of migraine is now available for prescription. Trudhesa, or ...

Impel NeuroPharma Begins Public Offering of 3 Million Shares

1mon ago, source: MarketWatch

Impel NeuroPharma Inc. said it has begun an underwritten public offering of three million common shares. All of the shares are being offered by Impel. The biopharmaceutical company said it intends ...

Impel NeuroPharma Inc. Shares Close the Day 11.7% Lower - Daily Wrap

29d ago, source: Nasdaq

Impel NeuroPharma Inc. (IMPL) shares closed today 11.7% lower than it did at the end of yesterday. The stock is currently down 3.7% year-to-date, down 3.7% over the past 12 months, and down 3.7% ...

One Impel NeuroPharma, Inc. (NASDAQ:IMPL) insider upped their stake in the previous year

1d ago, source: Yahoo Finance

From what we can see, insiders were net buyers in Impel NeuroPharma, Inc.'s (NASDAQ:IMPL ) during the past 12 months. That is, insiders acquired the stock in greater numbers than they sold it. While ...

Impel NeuroPharma Announces Trudhesa™ (Dihydroergotamine Mesylate) Nasal Spray is Now Available for Prescription for the Acute Treatment of Migraine

21d ago, source: Benzinga.com

28, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (NASDAQ:IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases with high ...

Impel NeuroPharma Inc IMPL

5d ago, source: Morningstar%2c Inc.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Impel NeuroPharma, Inc. (IMPL)

26d ago, source: Yahoo Finance

Stock futures slip after S&P 500's best day since July; bitcoin falls 5% on China crypto crackdown ...

Your Portfolio